Rapid high-performance liquid chromatography-tandem mass spectrometry method for determination of pentoxifylline and its active metabolites M1 and M5 in human plasma and its application in bioavailability study

Talanta

Volumn 82, Issue 3, 2010, Pages 945-951

  Vlase, Laurian ^a   Kiss, Béla ^a   Muntean, Dana ^a   Leucua, Sorin E ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Bioequivalence; Liquid chromatography mass spectrometry; Metabolites; Pentoxifylline; Plasma

Indexed keywords

BIOCHEMISTRY; BIOMOLECULES; ION SOURCES; LIQUIDS; MASS SPECTROMETERS; MASS SPECTROMETRY; METABOLITES; PLASMA (HUMAN); PLASMAS;

BIOEQUIVALENCE; CHROMATOGRAPHIC SEPARATIONS; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRIES; ION TRAP MASS SPECTROMETER; LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY; MULTIPLE-REACTION MONITORING MODES; PENTOXIFYLLINE; SELECTIVE LIQUID CHROMATOGRAPHY;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 77955425850     PISSN: 00399140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.talanta.2010.05.064     Document Type: Article

References (38)

1. R. Muller J. Med. 12 1981 209 235
2. B. Accetto Am. Heart J. 103 1982 864 869
3. A.G. Dettori, M. Pini, A. Moratti, M. Paolicelli, P. Basevi, R. Quintavalla, C. Manotti, and C. Di Lecce Angiology 40 1989 237 248
4. J.P. De La Cruz, M.M. Romero, P. Sanchez, and F. Sanchez De La Cuesta Gen. Pharmacol. 24 1993 605 609
5. D. Moher, B. Pham, M. Ausejo, A. Saenz, S. Hood, and G.G. Barber Drugs 59 2000 1057 1070
6. B. Angelkort, N. Maurin, and K. Boateng Curr. Med. Res. Opin. 6 1979 255 258
7. A. Ward, and S.P. Clissold Drugs 34 1987 50 97
8. B. Beermann, R. Ings, J. Mansby, J. Chamberlain, and A. McDonald Clin. Pharmacol. Ther. 37 1985 25 28
9. R.V. Smith, E.S. Waller, J.T. Doluisio, M.T. Bauza, S.K. Puri, I. Ho, and H.B. Lassman J. Pharm. Sci. 75 1986 47 52
10. T.A. Bryce, and J.L. Burrows J. Chromatogr. 181 1980 355 361
11. M. Nicklasson, S. Björkman, B. Roth, M. Jönsson, and P. Höglund Chirality 14 2002 643 652
12. M.T. Bauza, R.V. Smith, D.E. Knutson, and F.R. Witte J. Chromatogr. B: Biomed. Sci. Appl. 310 1984 61 69
13. J.L. Burrows, and K.W. Jolley J. Chromatogr. B: Biomed. Sci. Appl. 344 1985 187 198
14. J.L. Burrows J. Chromatogr. B: Biomed. Sci. Appl. 423 1987 139 146
15. D.A. Engelhart, E.S. Lavins, S.S. Seligman, and C.A. Sutheimer J. Anal. Toxicol. 21 1997 576 579
16. V. Marko, and K. Bauerova Biomed. Chromatogr. 5 2005 256 261
17. W. Rieck, and D. Platt J. Chromatogr. B: Biomed. Sci. Appl. 305 1984 419 427
18. G. Musch, T. Hamoir, and D.L. Massart J. Chromatogr. B: Biomed. Sci. Appl. 495 1989 215 226
19. W.E. Lambert, M.A. Yousouf, B.M. Van Liedekerke, J.E. De Roose, and A.P. De Leenheer Clin. Chem. 35 1989 298 301
20. A. Mancinelli, S. Pace, A. Marzo, E. Arrigoni Martelli, and G. Passetti J. Chromatogr. B: Biomed. Sci. Appl. 575 1992 101 107
21. M. Pokrajac, B. Miljkovic, D. Simic, B. Brzakovic, and A. Galetin Eur. J. Pharm. Biopharm. 43 1997 193 196
22. J.W. Wong, K.H. Yuen, and K.K. Peh J. Chromatogr. B 716 1998 387 391
23. P.B. Kyle, K.G. Adcock, R.E. Kramer, and R.C. Baker Biomed. Chromatogr. 19 2005 231 236
24. N.V.S. Ramakrishna, K.N. Vishwottam, S. Manoj, M. Koteshwara, M. Santosh, and Y. Anjaneyulu Chromatographia 63 2006 135 141
25. A. Chmielewska, L. Konieczna, A. Plenis, and H. Lamparczyk Acta Chromatogr. 16 2006 70 79
26. J.M. Raoul, M.R. Peterson, and T.C. Peterson Biochem. Pharmacol. 74 2007 639 646
27. A.K. Starodubtsev, I.V. Zolkina, S.N. Kondratenko, and G.A. Belyakova Pharm. Chem. J. 42 2008 1 3
28. P. Sripalakit, and A. Saraphanchotiwitthaya J. AOAC Int. 92 2009 837 845
29. Z.S. Teksin, I. Agabeyoglu, and K. Yamac J. Bioequiv. Availab. 1 2009 115 120
30. B.M. Best, J.C. Burns, J. DeVincenzo, S.J. Phelps, J.L. Blumer, J.T. Wilson, E.V. Capparelli, and J.D. Connor Curr. Ther. Res. 64 2003 96 115
31. T. Kumazawa, K. Sato, S. Hiroshi, A. Ishii, and O. Suzuki Forensic Sci. Int. 68 1994 53 67
32. N. Kuroda, Y. Hamachi, N. Aoki, M. Wada, M. Tanigawa, and K. Nakashima Biomed. Chromatogr. 13 1999 340 343
33. In vivo bioequivalence guidances, Drug protocols, Pentoxifylline Extended-Release Tablets - In Vivo Bioequivalence and In Vitro Dissolution Testing [online] [cited 2010 May 21]. Available from: URL: http://www. drugfuture.com/Pharmacopoeia/USP32/pub/data/v32270/usp32nf27s0-c1090.html
34. T.M. Annesley Clin. Chem. 49 2003 1041 1044
35. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research Guidance for Industry-Bioanalytical Method Validation 2001 May, http://www.fda.gov/cder/ guidance/4252fnl.pdf
36. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research Guidance for Industry. Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations March 2003 Rockville, USA, http://www.fda.gov/ cder/guidance/5356fnl.pdf
37. The European Agency for the Evaluation of Medicinal Products, Note for Guidance on the Investigation of Bioavailability and Bioequivalence, CPMP/EWP/QWP/1401/98, July 2001, London, UK, http://www.emea.europa.eu/pdfs/ human/qwp/140198enfin.pdf.
38. M.M. Kushnir, A.L. Rockwood, G.J. Nelson, B. Yue, and F.M. Urry Clin. Biochem. 38 2005 319 327